Cyclerion Therapeutics, Inc.
CYCN
|
NASDAQ
|
0 Followers
Company Quality
Profitability Score
17/100
Solvency Score
50/100
Dividends
Dividends data currently unavailable.Earnings
8/5/2025
in 56 days
-
Revenue est.
-
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sector
Biotechnology
Industry
Dr. Regina M. Graul Ph.D.
CEO
1
Employees
Cambridge
Headquarters
US
Country
Key Metrics TTM
Valuation
Market cap.
$10MEnterprise Value
$6.6MPrice to Earnings
-2.76Price to Sales
4.91Price to Book
0.93Price to Cash Flow
-2.98Profitability
Return on Assets
-29.90%Return on Equity
-34.02%Return on Invested Capital
-39.49%Gross Margin
96.11%Operating Margin
-166.60%Net Margin
-141.47%Liquidity
Quick Ratio
4.21Current Ratio
4.21Cash Ratio
3.41Inventory Turnover
0.00Asset Turnover
0.21Total Liabilities
$1.1MSolvency
Debt to Assets
0.00Debt to Equity
N/AInterest Coverage
0.00Equity Ratio
0.89Long-term Debt to Cap.
0.00Altman Z-Score
-33.80Performance
Earnings Waterfall
Debt level and coverage
Earnings
Feed
There are no posts to show right now.